xmg1 2 (Bio X Cell)
Bio X Cell is a verified supplier 
Bio X Cell manufactures this product 
96
Structured Review
Bio X Cell
xmg1 2
Xmg1 2, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 250 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/xmg1+2/InVivoPlus+anti-mouse+IFN%CE%B3/10__1158_slash_2326___6066__cir___25___0651-66-62-63
Average 96 stars, based on 250 article reviews
Xmg1 2, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 250 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/xmg1+2/InVivoPlus+anti-mouse+IFN%CE%B3/10__1158_slash_2326___6066__cir___25___0651-66-62-63
Average 96 stars, based on 250 article reviews
xmg1 2 - by Bioz Stars,
2026-11
96/100 stars
Images
Related Articles
Mouse Assay:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: .. Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); anti-mouse NK1.1, InVivoPlus, clone PK136 (BioXCell Cat. BP0036, RRID:AB_2894792) and the relative isotype control rat IgG2a, InVivoPlus, clone C1.18.4 (BioXCell Cat. BP0085, RRID:AB_1107771); anti-IFNInVivoPlus, clone Injection:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: .. Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); anti-mouse NK1.1, InVivoPlus, clone PK136 (BioXCell Cat. BP0036, RRID:AB_2894792) and the relative isotype control rat IgG2a, InVivoPlus, clone C1.18.4 (BioXCell Cat. BP0085, RRID:AB_1107771); anti-IFNInVivoPlus, clone Article Title: Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer Article Snippet: For DT-mediated cell depletion, DT (Sigma-Aldrich) was diluted in PBS (GIBCO) and administered intraperitoneally ( i.p. ) to deplete FoxP3 + Treg cells in FoxP3 DTR mice, FoxP3 DTR /WT and FoxP3 DTR / Ifngr1 −/− BMCs (1μg DT/mouse) or XCR1 + DC1 in XCR1 DTR mice, XCR1 DTR /WT and XCR1 DTR / H2-Ab1 −/− BMCs (0.5μg DT/mouse) at the indicated timepoints. .. For in vivo treatments, mice were injected with 100 μg αCD28 antibody i.p. (clone 37.51, Bio X Cell), 1.42x10 −11 mol IL-12 protein fused to murine serum albumin r.o. (IL-12-MSA, manufactured in-house) or 200 μg IFNγ antibody i.p. ( Bioprocessing:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: .. Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); anti-mouse NK1.1, InVivoPlus, clone PK136 (BioXCell Cat. BP0036, RRID:AB_2894792) and the relative isotype control rat IgG2a, InVivoPlus, clone C1.18.4 (BioXCell Cat. BP0085, RRID:AB_1107771); anti-IFNInVivoPlus, clone Article Title: Memory CD8 T cells are vulnerable to chronic IFN-γ signals but not to CD4 T cell deficiency in MHCII-deficient mice Article Snippet: .. Antibody for in vivo experiments; Anti-mouse IFN- ( Control:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: .. Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); anti-mouse NK1.1, InVivoPlus, clone PK136 (BioXCell Cat. BP0036, RRID:AB_2894792) and the relative isotype control rat IgG2a, InVivoPlus, clone C1.18.4 (BioXCell Cat. BP0085, RRID:AB_1107771); anti-IFNInVivoPlus, clone Transplantation Assay:Article Title: IL-1R2 Deficiency Unleashes Neutrophil-Mediated Antitumor Potential in Sarcoma Article Snippet: .. Mice were injected intraperitoneally (i.p.) with 200 μg of specific monoclonal antibodies or inhibitors: anti-mouse CD8, InVivoPlus, clone YTS169.4 (BioXCell Cat. BP0117, RRID:AB_2894806) and the relative isotype control rat IgG2b, InVivoPlus, clone LTF-2 (BioXCell Cat. BP0090, RRID:AB_1107780); anti-mouse NK1.1, InVivoPlus, clone PK136 (BioXCell Cat. BP0036, RRID:AB_2894792) and the relative isotype control rat IgG2a, InVivoPlus, clone C1.18.4 (BioXCell Cat. BP0085, RRID:AB_1107771); anti-IFNInVivoPlus, clone other:Article Title: Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer Article Snippet: Cell fixation was achieved using the Foxp3 Transcription Factor Fixation/Permeabilization buffer (eBioscience) when staining for transcription factors, or the Cytofix/Cytoperm Fixation/Permeabilization buffer (BD Biosciences) when staining for cytokines, following manufacturer’s instructions. In Vivo:Article Title: Tissue-specific abundance of interferon-gamma drives regulatory T cells to restrain DC1-mediated priming of cytotoxic T cells against lung cancer Article Snippet: For DT-mediated cell depletion, DT (Sigma-Aldrich) was diluted in PBS (GIBCO) and administered intraperitoneally ( i.p. ) to deplete FoxP3 + Treg cells in FoxP3 DTR mice, FoxP3 DTR /WT and FoxP3 DTR / Ifngr1 −/− BMCs (1μg DT/mouse) or XCR1 + DC1 in XCR1 DTR mice, XCR1 DTR /WT and XCR1 DTR / H2-Ab1 −/− BMCs (0.5μg DT/mouse) at the indicated timepoints. .. For in vivo treatments, mice were injected with 100 μg αCD28 antibody i.p. (clone 37.51, Bio X Cell), 1.42x10 −11 mol IL-12 protein fused to murine serum albumin r.o. (IL-12-MSA, manufactured in-house) or 200 μg IFNγ antibody i.p. ( Article Title: Memory CD8 T cells are vulnerable to chronic IFN-γ signals but not to CD4 T cell deficiency in MHCII-deficient mice Article Snippet: .. Antibody for in vivo experiments; Anti-mouse IFN- ( Article Title: IL-6 fuels durable memory for Th17 cell-mediated responses to tumors Article Snippet: .. In vivo blocking or neutralizing antibodies were purchased from BioXCell: (anti-IL-6, clone MP5-20F3; anti-IL-6R, clone 15A7; anti-IL-17A, clone 17F3; anti-IFN-γ, clone Neutralization:Article Title: Intratumourally injected alum-tethered cytokines elicit potent and safer local and systemic anticancer immunity. Article Snippet: Depletions of immune cells were done using antibodies against CD8 (clone 2.43, BioXCell 400 ug i.p. twice weekly), NK1.1 (clone PK136, BioXCell, 400 ug i.p. twice weekly), Ly6g (clone 1A8, BioXCell, 400 ug i.p. twice weekly) or CSF1R (clone AFS98, BioXCell, 300 ug i.p. every other day) as previously described. .. Cytokine neutralization was done using i.p. treatments with 200 ug of antibodies against IFN- ( Produced:Article Title: Memory CD8 T cells are vulnerable to chronic IFN-γ signals but not to CD4 T cell deficiency in MHCII-deficient mice Article Snippet: .. Antibody for in vivo experiments; Anti-mouse IFN- ( Blocking Assay:Article Title: IL-6 fuels durable memory for Th17 cell-mediated responses to tumors Article Snippet: .. In vivo blocking or neutralizing antibodies were purchased from BioXCell: (anti-IL-6, clone MP5-20F3; anti-IL-6R, clone 15A7; anti-IL-17A, clone 17F3; anti-IFN-γ, clone |